{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:19:06Z","timestamp":1790014746623,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:00:00Z","timestamp":1570579200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:00:00Z","timestamp":1570579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s40264-019-00865-8","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T15:16:46Z","timestamp":1572448606000},"page":"1507-1513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4395-2445","authenticated-orcid":false,"given":"Brahim","family":"Azzouz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukshe","family":"Kanagaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Herlem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Trenque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,9]]},"reference":[{"issue":"2","key":"865_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol JEADV. 2017;31(2):205\u201312.","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"key":"865_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Su\u00e1rez-Fari\u00f1as M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227\u201355.","journal-title":"Annu Rev Immunol"},{"issue":"9583","key":"865_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263\u201371.","journal-title":"Lancet."},{"issue":"2","key":"865_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.molimm.2014.12.014","volume":"64","author":"A Chandra","year":"2015","unstructured":"Chandra A, Ray A, Senapati S, Chatterjee R. Genetic and epigenetic basis of psoriasis pathogenesis. Mol Immunol. 2015;64(2):313\u201323.","journal-title":"Mol Immunol"},{"issue":"3","key":"865_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2165\/00128071-200001030-00003","volume":"1","author":"N Tsankov","year":"2000","unstructured":"Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis. Recognition and management. Am J Clin Dermatol. 2000;1(3):159\u201365.","journal-title":"Am J Clin Dermatol."},{"key":"865_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3899\/jrheum.090227","volume":"83","author":"F Rongioletti","year":"2009","unstructured":"Rongioletti F, Fiorucci C, Parodi A. Psoriasis induced or aggravated by drugs. J Rheumatol Suppl. 2009;83:59\u201361.","journal-title":"J Rheumatol Suppl"},{"issue":"1","key":"865_CR7","first-page":"32","volume":"3","author":"GK Kim","year":"2010","unstructured":"Kim GK, Del Rosso JQ. Drug-provoked psoriasis: is it drug induced or drug aggravated? J Clin Aesthetic Dermatol. 2010;3(1):32\u20138.","journal-title":"J Clin Aesthetic Dermatol."},{"issue":"4","key":"865_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10557-010-6244-x","volume":"24","author":"R Ferrari","year":"2010","unstructured":"Ferrari R, Guardigli G, Ceconi C. Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium. Cardiovasc Drugs Ther. 2010;24(4):331\u20139.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"865_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20(2):109\u201317.","journal-title":"Drug Saf"},{"issue":"2","key":"865_CR10","first-page":"69","volume":"68","author":"Y Arimone","year":"2013","unstructured":"Arimone Y, Bidault I, Dutertre J-P, G\u00e9rardin M, Guy C, Haramburu F, et al. Updating the French method for the causality assessment of adverse drug reactions. Th\u00e9rapie. 2013;68(2):69\u201376.","journal-title":"Th\u00e9rapie."},{"issue":"6","key":"865_CR11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","volume":"72","author":"J-L Montastruc","year":"2011","unstructured":"Montastruc J-L, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011;72(6):905\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"865_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1469-1809.1955.tb01348.x","volume":"19","author":"B Woolf","year":"1955","unstructured":"Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19(4):251\u20133.","journal-title":"Ann Hum Genet"},{"issue":"2","key":"865_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/JCP.0b013e31819a4b7c","volume":"29","author":"YB Brauchli","year":"2009","unstructured":"Brauchli YB, Jick SS, Curtin F, Meier CR. Lithium, antipsychotics, and risk of psoriasis. J Clin Psychopharmacol. 2009;29(2):134\u201340.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"865_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1540-9740.2006.04515.x","volume":"5","author":"D Antonov","year":"2006","unstructured":"Antonov D, Grozdev I, Pehlivanov G, Tsankov N. Psoriatic erythroderma associated with enalapril. Skinmed. 2006;5(2):90\u20132.","journal-title":"Skinmed."},{"issue":"1","key":"865_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MJT.0b013e31818f9e99","volume":"17","author":"P Thakor","year":"2010","unstructured":"Thakor P, Padmanabhan M, Johnson A, Pararajasingam T, Thakor S, Jorgensen W. Ramipril-induced generalized pustular psoriasis: case report and literature review. Am J Ther. 2010;17(1):92\u20135.","journal-title":"Am J Ther"},{"issue":"1","key":"865_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000247861","volume":"181","author":"R Wolf","year":"1990","unstructured":"Wolf R, Tamir A, Brenner S. Psoriasis related to angiotensin-converting enzyme inhibitors. Dermatologica. 1990;181(1):51\u20133.","journal-title":"Dermatologica."},{"issue":"2","key":"865_CR17","first-page":"162","volume":"40","author":"R Wolf","year":"1987","unstructured":"Wolf R, Dorfman B, Krakowski A. Psoriasiform eruption induced by captopril and chlorthalidone. Cutis. 1987;40(2):162\u20134.","journal-title":"Cutis"},{"issue":"6609","key":"865_CR18","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1136\/bmj.295.6609.1352","volume":"295","author":"NW Hamlet","year":"1987","unstructured":"Hamlet NW, Keefe M, Kerr RE. Does captopril exacerbate psoriasis? Br Med J Clin Res Ed. 1987;295(6609):1352.","journal-title":"Br Med J Clin Res Ed."},{"issue":"5","key":"865_CR19","first-page":"274","volume":"37","author":"TT Hauschild","year":"1986","unstructured":"Hauschild TT, Bauer R, Kreysel HW. Initial manifestation of eruptive exanthematous psoriasis vulgaris caused by captopril medication. Hautarzt Z Dermatol Venerol Verwandte Geb. 1986;37(5):274\u20137.","journal-title":"Hautarzt Z Dermatol Venerol Verwandte Geb."},{"issue":"963","key":"865_CR20","first-page":"392","volume":"106","author":"DM Coulter","year":"1993","unstructured":"Coulter DM, Pillans PI. Angiotensin-converting enzyme inhibitors and psoriasis. N Z Med J. 1993;106(963):392\u20133.","journal-title":"N Z Med J"},{"issue":"3","key":"865_CR21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0190-9622(08)81761-6","volume":"28","author":"P Gilleaudeau","year":"1993","unstructured":"Gilleaudeau P, Vallat VP, Carter DM, Gottlieb AB. Angiotensin-converting enzyme inhibitors as possible exacerbating drugs in psoriasis. J Am Acad Dermatol. 1993;28(3):490\u20132.","journal-title":"J Am Acad Dermatol"},{"issue":"23","key":"865_CR22","first-page":"3335","volume":"157","author":"JG Eriksen","year":"1995","unstructured":"Eriksen JG, Christiansen JJ, Asmussen I. Postulosis palmoplantaris caused by angiotensin-converting enzyme inhibitors. Ugeskr Laeger. 1995;157(23):3335\u20136.","journal-title":"Ugeskr Laeger"},{"issue":"3","key":"865_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000073106","volume":"207","author":"PG Stavropoulos","year":"2003","unstructured":"Stavropoulos PG, Kostakis PG, Papakonstantinou AMK, Panagiotopoulos A, Petridis AD. Coexistence of psoriasis and pemphigus after enalapril intake. Dermatol Basel Switz. 2003;207(3):336\u20137.","journal-title":"Dermatol Basel Switz."},{"issue":"3","key":"865_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3109\/08923973.2013.797992","volume":"35","author":"GA Vena","year":"2013","unstructured":"Vena GA, Cassano N, Coco V, De Simone C. Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. Immunopharmacol Immunotoxicol. 2013;35(3):447\u201350.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"865_CR25","unstructured":"Perrine AL, Lecoffre C, Blacher J, Oli\u00e9 V. L\u2019hypertension art\u00e9rielle en France: pr\u00e9valence, traitement et contr\u00f4le en 2015 et \u00e9volutions depuis 2006. Bull Epid\u00e9miol Hebd. 2018;(10):170\u20139. \nhttp:\/\/invs.santepubliquefrance.fr\/beh\/2018\/10\/2018_10_1.html\n\n."},{"key":"865_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7525-4-35","volume":"4","author":"MJ Bhosle","year":"2006","unstructured":"Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4:35.","journal-title":"Health Qual Life Outcomes."},{"issue":"9","key":"865_CR27","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamadermatol.2014.1019","volume":"150","author":"AW Armstrong","year":"2014","unstructured":"Armstrong AW. Psoriasis provoked or exacerbated by medications: identifying culprit drugs. JAMA Dermatol. 2014;150(9):963.","journal-title":"JAMA Dermatol."},{"issue":"5","key":"865_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385\u201396.","journal-title":"Drug Saf"},{"issue":"2","key":"865_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0378-6323.39688","volume":"74","author":"VN Sehgal","year":"2008","unstructured":"Sehgal VN, Dogra S, Srivastava G, Aggarwal AK. Psoriasiform dermatoses. Indian J Dermatol Venereol Leprol. 2008;74(2):94.","journal-title":"Indian J Dermatol Venereol Leprol."},{"issue":"4","key":"865_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/00015550510032823","volume":"85","author":"AD Cohen","year":"2005","unstructured":"Cohen AD, Bonneh DY, Reuveni H, Vardy DA, Naggan L, Halevy S. Drug exposure and psoriasis vulgaris: case\u2013control and case-crossover studies. Acta Derm Venereol. 2005;85(4):299\u2013303.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"865_CR31","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/j.1365-2133.2008.08563.x","volume":"158","author":"YB Brauchli","year":"2008","unstructured":"Brauchli YB, Jick SS, Curtin F, Meier CR. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case\u2013control study. Br J Dermatol. 2008;158(6):1299\u2013307.","journal-title":"Br J Dermatol"},{"issue":"9","key":"865_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/jamadermatol.2013.9957","volume":"150","author":"S Wu","year":"2014","unstructured":"Wu S, Han J, Li W-Q, Qureshi AA. Hypertension, antihypertensive medication use, and risk of psoriasis. JAMA Dermatol. 2014;150(9):957\u201363.","journal-title":"JAMA Dermatol."},{"issue":"1\u20133","key":"865_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2007.07.061","volume":"577","author":"C Ceconi","year":"2007","unstructured":"Ceconi C, Francolini G, Olivares A, Comini L, Bachetti T, Ferrari R. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. Eur J Pharmacol. 2007;577(1\u20133):1\u20136.","journal-title":"Eur J Pharmacol"},{"key":"865_CR34","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1002\/jcb.27569","volume":"120","author":"M Tanhapour","year":"2019","unstructured":"Tanhapour M, Falahi B, Vaisi-Raygani A, Bahrehmand F, Kiani A, Rahimi Z, et al. Angiotensin-converting enzyme insertion\/deletion (rs106180) and angiotensin type 1 receptor A1166 C (rs106165) genotypes and psoriasis: Correlation with cellular immunity, lipid profile, and oxidative stress markers. J Cell Biochem. 2019;120:2627\u201333.","journal-title":"J Cell Biochem"},{"issue":"28","key":"865_CR35","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Eur Heart J. 2013;34(28):2159\u2013219.","journal-title":"Eur Heart J"},{"key":"865_CR36","first-page":"87","volume":"7","author":"DM Balak","year":"2017","unstructured":"Balak DM, Hajdarbegovic E. Drug-induced psoriasis: clinical perspectives. Psoriasis Auckl NZ. 2017;7:87\u201394.","journal-title":"Psoriasis Auckl NZ."},{"issue":"1","key":"865_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1574890110666151116144725","volume":"10","author":"VM Campese","year":"2015","unstructured":"Campese VM, Lakdawala R. The challenges of blood pressure control in dialysis patients. Recent Adv Cardiovasc Drug Discov. 2015;10(1):34\u201359.","journal-title":"Recent Adv Cardiovasc Drug Discov."},{"key":"865_CR38","unstructured":"ACE-inhibitors and psoriasis. \nhttps:\/\/www.lareb.nl\/en\/news\/ace-inhibitors-and-psoriasis\/\n\n. Accessed 8 Oct 2018"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-019-00865-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-019-00865-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-019-00865-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T23:35:00Z","timestamp":1602113700000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-019-00865-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,9]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1007\/s40264-019-00865-8","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,9]]},"assertion":[{"value":"9 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were used to assist in the preparation of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Brahim Azzouz, Aurore Morel, Emmanuelle Herlem, Lukshe Kanagaratnam\u00a0and Thierry Trenque have no conflicts of interest that are directly relevant to the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}